Jessica F Partin

Summary

Affiliation: Akron General Medical Center
Country: USA

Publications

  1. ncbi Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer
    Jessica F Partin
    Akron General Medical Center, Akron, OH, USA
    Ann Surg Oncol 18:3399-406. 2011

Detail Information

Publications1

  1. ncbi Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer
    Jessica F Partin
    Akron General Medical Center, Akron, OH, USA
    Ann Surg Oncol 18:3399-406. 2011
    ..Small, single-institution series have shown that, compared with standard clinicopathologic criteria, use of RS significantly affects adjuvant chemotherapy recommendations...